Raffles Medical Group

The new five-storey mall at Holland Village developed by Raffles Medical Group (RMG) has officially opened. Spanning a gross floor area (GFA) of 62,720 sq ft, and built at a cost of about $120 million (including the property purchase consideration), it re

SINGAPORE (Oct 25): Healthcare provider Raffles Medical Group is expanding rapidly and analysts are divided on recommendations on its stock.

SINGAPORE (Oct 9): Raffles Medical Group announced a 4% rise in 3Q earnings to $16.2 million from $15.6 million the year before, due to positive revenue contributions from all segments of the group.

SINGAPORE (Oct 17): After posting 5% earnings growth in 2QFY16, RHB Research Cai is still maintaining its “buy” rating on the stock with a target price of $1.70 as it believes the group has more room to grow.

SINGAPORE (Oct 6): Fullerton Healthcare Corp has lodged its draft listing prospectus on Sept 28, indicating its intention to sell 140.3 million shares, excluding the overallotment option, at an “indicative” price of $1.73 a share.

SINGAPORE (Sept 29): Daiwa Capital Markets is keeping its “hold” rating on Raffles Medical Group RMG) at an unchanged target price of $1.57 as the group continues its press ahead with its expansion plans.

SINGAPORE (Sept 26): A perceived quality gap continues to hound Malaysian hospitals, keeping Singapore patients away despite the promise of lower healthcare costs, says Maybank Kim Eng.

SINGAPORE (Aug 26): OCBC Investment Research has maintained its “hold” recommendation for Raffles Medical Group with a fair value of $1.54, after taking into account the near-term cost pressures seen in its 2Q results.

SINGAPORE (July 27) – DBS has maintained its “hold” call for Raffles Medical Group, with a target price of $1.43.